Prevalence of Self-Reported Physician Diagnosis of Chronic Hand Eczema in Adults: A Cross-Sectional Study of More Than 10,000 Participants in the General Population – Results From the CHECK Study in the United States
Main Article Content
Keywords
Prevalence, Chronic Hand Eczema
References
2. Thyssen JP, Schuttelaar MLA, Alfonso JH et al. Arents BWM, et al. Guidelines
for diagnosis, prevention, and treatment of hand eczema. Contact Dermatitis. 2022;86(5):357-78.
3. Agner T, Elsner P. Hand eczema: epidemiology, prognosis and prevention. J Eur Acad Dermatol Venereol. 2020;34 Suppl 1:4-12.
4. Vindenes HK, Svanes C, Lygre SHL et al. Prevalence of, and workrelated risk factors for, hand eczema in a Norwegian general population (The HUNT Study). Contact Dermatitis. 2017;77(4):214-23.
5. Bingefors K, Svensson Å, Isacson D, Lindberg M. Self-reported lifetime prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood: a
population-based cross-sectional survey. Acta Derm Venereol. 2013;93(4):438-41.
6. Johannisson A, Pontén A, Svensson Å. Prevalence, incidence and predictive factors for hand eczema in young adults - a follow-up study. BMC Dermatol. 2013;13:14.
7. Elsner P, Agner T. Hand eczema: a 'neglected' disease. J Eur Acad Dermatol Venereol. 2020;34 Suppl 1:3.
8. Silverberg JI, Guttman-Yassky E, Agner T et al. Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council. Dermatitis. 2021;32(5):319-326.
9. Thyssen JP, Silverberg JI, Guttman-Yassky E. Chronic hand
eczema understanding has ramifications on clinical management. J Eur Acad Dermatol Venereol. 2020;34(8):e429-e30.
10. Apfelbacher C, Bewley A, Molin S, Fargnoli MC, Giménez-Arnau AM, Brignoli L, Rault B, Norlin JM, Skaaby T, Crépy MN. Prevalence of chronic hand eczema in adults: a crosssectional survey of over 60,000 respondents from the general population of Canada, France, Germany, Italy, Spain and the UK. Br J Dermatol. 2025;192(6):1047–1054.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.